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Abstract
Objective—To estimate the incidence of selected systemic autoimmune diseases (SAIDs) in 
approximately 14,000 male rescue/recovery workers enrolled in the Fire Department of the City of 
New York (FDNY) World Trade Center (WTC) Health Program and to compare FDNY incidence 
to rates from demographically similar men in the Rochester Epidemiology Project (REP), a 
population-based database in Olmsted County, Minnesota.
Patients and Methods—We calculated incidence for specific SAIDs (rheumatoid arthritis, 
psoriatic arthritis, systemic lupus erythematosus, and others) and combined SAIDs diagnosed from 
September 12, 2001, through September 11, 2014, and generated expected sex- and age-specific 
rates based on REP rates. Rates were stratified by level of WTC exposure (higher vs lower). 
Standardized incidence ratios (SIRs), which are the ratios of the observed number of cases in the 
FDNY group to the expected number of cases based on REP rates, and 95% CIs were calculated.
Results—We identified 97 SAID cases. Overall, FDNY rates were not significantly different 
from expected rates (SIR, 0.97; 95% CI, 0.77–1.21). However, the lower WTC exposure group had 
9.9 fewer cases than expected, whereas the higher WTC exposure group had 7.7 excess cases.
Conclusion—Most studies indicate that the healthy worker effect reduces the association 
between exposure and outcome by about 20%, which we observed in the lower WTC exposure 




Mayo Clin Proc. Author manuscript; available in PMC 2017 January 01.
Published in final edited form as:













group. Overall rates masked differences in incidence by level of WTC exposure, especially 
because the higher WTC exposure group was relatively small. Continued surveillance for early 
detection of SAIDs in high WTC exposure populations is required to identify and treat exposure-
related adverse effects.
Systemic autoimmune diseases (SAIDs) are relatively rare in North American and European 
populations and predominantly affect women (>75% of cases). Published incidence and 
prevalence estimates vary considerably, due, in part, to differences in characteristics of the 
underlying population that are associated with disease prevalence. Further, diagnoses may be 
based on clinical judgment rather than diagnostic criteria. The few studies of SAID 
incidence in occupational cohorts are subject to similar limitations, relying on self-reported 
diagnoses from survey responses1,2 or on diagnoses from death certificates.3 The lack of 
SAID incidence studies in specific occupational groups impedes efforts to identify 
nongenetic risk factors that might contribute to differences in disease distribution by 
occupation and over time.
The terrorist attacks on the World Trade Center (WTC) on September 11, 2001 (9/11), with 
subsequent building collapses and fires, exposed thousands of rescue/recovery workers and 
residents to aerosolized WTC dust— an amalgam of pulverized cement, glass fibers, silica, 
asbestos, lead, polycyclic aromatic hydrocarbons, polychlorinated biphenyls, and 
polychlorinated furans and dioxins.4 Environmental sampling of the area around New York 
City identified 287 chemicals and chemical groups5; some had previously been linked to 
SAIDs in non— WTC-exposed workers.
The Fire Department of the City of New York (FDNY) WTC Health Program monitors a 
cohort of approximately 16,000 firefighters and emergency medical service (EMS) workers 
who participated in rescue/recovery efforts at the WTC site. Clinical observations of SAIDs 
in this mostly healthy, white male cohort triggered an interest in estimating the incidence of 
SAIDs in this population. The current study includes the following diagnoses: rheumatoid 
arthritis (RA), spondyloarthritis (psoriatic arthritis, seronegative arthritis, and ankylosing 
spondylitis), systemic lupus erythematosus (SLE), inflammatory myositis (polymyositis and 
dermatomyositis), antiphospholipid syndrome, Sjögren syndrome, systemic sclerosis 
(scleroderma), granulomatosis with polyangiitis (formerly, Wegener granulomatosis), and 
eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). We excluded 
sarcoidosis because we6 and others7,8 have previously reported on sarcoidosis after WTC 
exposure.
The primary study aims were to (1) estimate the incidence of SAIDs from September 12, 
2001, through September 11, 2014, in male WTC-exposed FDNY rescue/recovery workers 
and (2) compare SAID incidence in our WTC-exposed cohort to rates from demographically 
similar men from Olmsted County, Minnesota, and to other published rates.
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Fire Department of the City of New York
We obtained information from FDNY employee databases, self-administered health 
questionnaires, FDNY physician records, and rheumatologist-reviewed patient medical 
records and self-reported information.
The FDNY WTC Health Program schedules monitoring evaluations of the WTC-exposed 
workforce every 12 to 18 months. This visit includes a physical examination and completion 
of a self-administered health questionnaire. In 2005, we added a question about doctor-
diagnosed SAIDs, and in 2009, we created an autoimmune registry to capture potential cases 
in 2 ways. Most commonly, potential cases were reported on the physical health 
questionnaires. Specifically, the question asks: “Since your last FDNY WTC annual 
medical, has a doctor or health professional told you that you have arthritis or any 
autoimmune disease listed below?” Answer choices include “rheumatoid arthritis,” “lupus,” 
“polymyositis/ dermatomyositis,” and “other, for example, psoriatic arthritis or 
scleroderma.” Additionally, the registry included potential cases reported to an FDNY 
physician during a medical monitoring examination or a treatment visit. This information 
was recorded as part of the patient medical history.
The FDNY WTC disease registry clinician (N.J.) called all 739 patients in the autoimmune 
registry who potentially had SAID; 522 (70.6%) reported no diagnosis of autoimmune 
disease by a physician and were determined to be “reporting errors.” Of the remaining 217 
possible cases, 63 were confirmed by documentation from treating physicians/
rheumatologists that included the specific SAID diagnosis, treatment plan (medications), and 
approximate diagnosis date (month and year). We also identified 34 “probable” cases. 
Probable cases were patients who did not submit adequate documentation from their treating 
physician by the close of the study but reported an SAID diagnosis, met criteria of the initial 
screening phone call, and provided at least one piece of evidence supporting an SAID 
diagnosis, most commonly a medication used almost exclusively for SAIDs, as determined 
by 2 board-certified rheumatologists (J.B., B.Q.). Excluded possible cases (N=120) included 
61 patients that the rheumatologists concluded lacked sufficient evidence for probable SAID 
and 59 patients we were unable to contact by either phone or mail. The final case population 
consisted of 63 confirmed and 34 probable SAID cases (N =97). Confirmed diagnoses met 
American College of Rheumatology criteria for SAID.9–15 The study was approved by the 
institutional review board at Montefiore Medical Center.
WTC Exposure Ascertainment
We used 2 measures of WTC exposure. Time of initial arrival at the WTC site was taken 
from the first post-9/11 questionnaire, which was administered starting October 2, 2001. 
“Arrival time” was categorized as arriving on the morning of 9/11 vs arriving any time 
thereafter until July 25, 2002,16 when the site was closed to FDNY workers. Questions about 
duration of work at the WTC site were added to the monitoring questionnaires on October 
15, 2002. These questions asked members to indicate the months in which they worked at 
least 1 day at the WTC site between 9/11 and July 25, 2002.17 Duration (range, 1–10 
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months) was categorized as 7 or more vs 6 or fewer months. This split was chosen to 
designate 15.5% (n=2156) of the population as the high-duration group to match the 15.6% 
(n=2171) in the earliest arrival group to create a composite “higher WTC exposure measure” 
of WTC arrival during the morning of 9/11 and/or prolonged work at the WTC site for 7 or 
more months, classifying 28.2% (n=3912) of the population as “higher exposure.”
Study Population
The population at risk consisted of 14,966 WTC-exposed male firefighters and EMS 
workers. Inclusion criteria for this study required (1) having completed a monitoring 
questionnaire during or after 2005 to ensure the potential to self-report SAIDs, (2) not 
having a pre-9/11 SAID diagnosis, (3) having known exposure to the WTC site (known time 
and date of first arrival and number of months worked at the WTC site), (4) having a 
working telephone number, and (5) having provided written consent for research. The final 
study population totaled 13,892 patients (92.8% of the population at risk).
Rochester Epidemiology Project
The Rochester Epidemiology Project (REP) was established in 1966 and has medical 
records from over 700,000 former or current Olmsted County, Minnesota, residents. In 2010, 
the Olmsted County population included 70,485 males (82.8% white, n=58,328) compared 
with 13,892 males (88.5% white, n=12,294) in the FDNY cohort.18 The REP records 
include all conditions that come to medical attention in Olmsted County at Mayo Clinic and 
Olmsted Medical Center and their outpatient facilities, emergency rooms, and inpatient 
hospitalizations and from private practitioners, urgent care facilities, and nursing homes.
The REP provided age- and sex-specific incidence rates during a similar time period as the 
FDNY case accrual for the following 5 SAIDs: RA, psoriatic arthritis, ankylosing 
spondylitis, SLE, and scleroderma. Given their geographic distance from New York City 
(~1300 miles), it is likely that the REP participants are entirely non—WTC exposed. 
Occupational history was not available. For all REP cases, individual medical records were 
reviewed to validate the diagnosis using established diagnostic/ classification criteria.19,20
Statistical Analyses
We calculated incidence including both confirmed and rheumatologist-determined probable 
cases (N=97) for each specific SAID and for all SAIDs combined. The SAID incidence was 
calculated as the number of cases per 100,000 person-years. Person-time (denominator) 
accrual began on September 12, 2001, or the FDNY hire date, whichever was later. Follow-
up ended on the earliest of the following events: death of the participant, end of the study 
(September 11, 2014), or, for retired members, the last FDNY treatment or medical 
monitoring visit. Approximate 95% CIs were calculated for standardized incidence ratios 
(SIRs) using the Poisson distribution21 and for direct standardized incidence rates using the 
modified gamma approximation method,22 which assumes a Poisson distribution. Because 
for probable cases we only had self-identified year of diagnosis, age and date of diagnosis 
were estimated using age on July 1 of the diagnosis year. For external comparison with non-
FDNY cohorts, incidence rates were age adjusted to the US 2000 male population aged 18 
years and older (Table 1).
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To compare FDNY rates with REP rates in men, we generated age-specific expected 
numbers of cases for the FDNY cohort assuming that the REP rates applied to the FDNY 
cohort (Table 2). We compared rates by individual diagnoses and overall and also stratified 
by level of WTC exposure, higher vs lower. Standardized incidence ratios, which are the 
ratios of the observed number of cases in the FDNY cohort to the expected number of cases 
based on the REP rates, were calculated assuming that the expected rates are fixed and that 
the observed number of cases follows a Poisson distribution. An SIR of greater than 1 
indicates that the observed number of cases is higher than expected, and an SIR of less than 
1 indicates that the observed number of cases is lower than expected. All analyses were 
performed using SAS statistical software, version 9.4 (SAS Institute Inc).
RESULTS
We identified 63 confirmed and 34 probable cases of post-9/11 SAIDs diagnosed between 
September 12, 2001, and September 11, 2014 (Table 3). The mean age of the patients at 
diagnosis was 49.5 years (range, 28.4–69.4 years).
Ascertainment of exposure usually occurred well before diagnosis. The median time 
between ascertainment of arrival time at the WTC site from the monitoring questionnaire 
and diagnosis of SAID was 5.5 years; the median time between ascertainment of duration of 
exposure and diagnosis of SAID was 3.0 years because duration questions were a later 
addition to our monitoring program.
Table 4 presents selected characteristics of the study population by SAID status. Those with 
SAIDs were more likely to have had higher WTC exposure (36 of 3912 vs 61 of 9980; P=.
05). Standardized SAID incidence rates for men in the FDNY cohort (Table 1) ranged from 
19.0 per 100,000 person-years (95% CI, 12.1–28.9 per 100,000 person-years) for RA to 0.3 
per 100,000 person-years (95% CI, 0.0–4.8 per 100,000 person-years) for granulomatosis 
with polyangiitis. Table 5 presents incidence rates of selected SAIDs from published studies. 
We included only studies that provided sex-specific rates for men and were published after 
2000. The FDNY rates for RA are generally lower than published rates but appear to be 
higher for both SLE and inflammatory myositis. The underlying racial/ethnic composition of 
the population is sometimes not reported, which makes meaningful comparisons difficult.
Table 2 provides the observed number of incident SAIDs in the FDNY male cohort and the 
expected age- and sex-specific number of incident cases based on REP rates. The overall 
number of observed cases was similar to the number of expected cases (SIR, 0.97; 95% CI, 
0.77–1.21); the impact of the healthy worker effect is clear in the lower exposure group, in 
which we identified 9.93 fewer cases than expected (an incidence rate 17.1% below 
expectation based on REP data; SIR, 0.83; 95% CI, 0.61–1.10). The effect of higher WTC 
exposure is also evident—we identified 7.7 excess cases (34.4% above expectation based on 
the REP data; SIR, 1.34; 95% CI, 0.91–1.92).
Because REP rates were not available for all diagnoses, we compared rates within the FDNY 
cohort by level of WTC exposure in the polymyositis/dermatomyositis group. In the higher 
WTC exposure group, rates were about double the rates in the lower exposure group: 8.3 
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(95% CI, 3.1–22.2) vs 4.1 (95% CI, 1.7–9.9), a rate ratio of 2.0. Other individual diagnoses 
have too few cases for this comparison.
DISCUSSION
We found an excess of SAID cases in the higher WTC exposure group of FDNY rescue/
recovery workers. Projecting the deficit in cases observed in the lower exposure group, in 
which FDNY cases reached 83% of expectation, we would have anticipated 18.5 SAID 
cases among the higher exposure group, which is 11.5 cases fewer than were observed. This 
result of excess cases in the higher exposure group is supported by our recent case-control 
study35 which, using different methodology, found similar results. In that study, prolonged 
work exposure conferred a 13% increased risk for each month at the WTC site compared 
with risk in those who worked only 1 month, and early arrival at the WTC site during the 
morning of 9/11 conferred an additional independent risk (conditional odds ratio, 1.85; 95% 
CI, 0.86–3.89). In the current study, we required either early WTC arrival or long duration of 
work at the WTC site for inclusion in the higher WTC exposure category, in which 
individuals generally reached or exceeded expected SAID rates, whereas in the lower WTC 
exposure group, FDNY rates were mostly similar to or lower than expected rates. The REP 
reference rates were not available for all included diagnoses. Therefore, we investigated risk 
for some SAIDs using an internal comparison between FDNY rescue/recovery workers with 
higher and lower WTC exposure and found that rates were doubled in the higher exposure 
group.
For SLE, higher than expected rates were not limited to the higher exposure group; we 
observed excess cases in all WTC-exposed workers. In 2012, a National Institute of 
Environmental Health Sciences expert panel reported consensus findings, stating 
“confidence” in an association between SAIDs and crystalline silica.36 Crystalline silica has 
been well studied in occupational settings, and these previous studies have revealed 
associations with RA, SLE, and scleroderma.37,38 One explanation for the role of 
environmental factors like crystalline silica is that they induce the breakdown of tolerance in 
genetically susceptible individuals.39 Experimental data from animal models40 suggest that 
inhaled silica dust becomes trapped in the lungs and other tissues, and the resulting cycle of 
apoptosis, together with increased exposure to self-antigens and inflammation, leads to the 
development or acceleration of autoimmunity.41 Other silicates like asbestos may act 
similarly. This relationship may be partially obscured because some exposures are thought to 
lead to immune activation and/or antibodies but not necessarily to a specific SAID 
outcome.36 There may also be an extended latency period between exposure and disease that 
has not been well characterized. For example, in a military cohort, antinuclear antibodies at 
a 1:120 dilution were seen up to 9 years before diagnosis in a majority of patients.42
It is likely that WTC workers inhaled silica and numerous other elements because of the 
inadequate availability of effective respiratory protective equipment in the early post-9/11 
days and inadequate use of respirators thereafter. Evidence of the effects of the intensive 
exposure were obvious because more than 70% of FDNY workers reported one or more 
acute aerodigestive symptoms in the first post-9/11 year, which, for some, became FDNY-
diagnosed chronic conditions.43 Other evidence of lung injury comes from our longitudinal 
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analyses of forced expiratory volume in 1 second,44 which revealed a large decrease in 
pulmonary function—the equivalent of 10 to 13 years of normal age-related decline—in the 
first year after 9/11; the magnitude of the decrease was related to initial time of arrival at the 
WTC site.
The causes of SAIDs are unknown and likely multifactorial. Genetic susceptibility may be 
the critical first factor, followed by an antigenic event such as an environmental exposure 
and triggering of immunologic-inflammatory-oxidative pathways leading to an autoimmune 
response resulting in disease.36 Although the evidence of post-9/11 pulmonary compromise 
is compelling, there is also direct evidence of intrusion by foreign matter into the respiratory 
system of WTC-exposed workers prompting an inflammatory response.
Ten months after the WTC collapse, induced sputum samples from 39 FDNY firefighters 
were compared with samples from firefighters in Tel Aviv, Israel. In FDNY firefighters, the 
percentage of particles larger than 2 μm was greater, and the particles were more irregularly 
shaped and contained more identified elements and were associated with an inflammatory 
response.45 Recently, a study evaluated particles found in the lung tissue of 7 WTC-exposed 
individuals (nonfire-fighters) in whom interstitial lung inflammation and disease 
developed.46 This report identified aluminum and magnesium silicates, chrysotile asbestos, 
calcium phosphate and calcium sulfate, small shards of glass, and carbon nanotubes of 
various sizes and lengths in the lung biopsy specimens from some of these workers. Finally, 
markers of systemic inflammation that predict accelerated lung function decline have been 
found in the serum of FDNY WTC-exposed workers.47–49 These studies documenting 
intrusion of foreign matter leading to an inflammatory response lend biological plausibility 
to an association between WTC exposure and SAIDs.
Because we were unable to identify studies of SAID incidence in occupational cohorts, we 
summarized studies published since 2000 that provide population-based incidence rates for 
men to provide context for FDNY rates. However, these rates are not directly comparable for 
numerous reasons, especially because the healthy worker effect is striking in occupational 
cohorts like FDNY employees who have met stringent, prehire physical requirements. Most 
studies estimate that the healthy worker effect reduces the association between exposure and 
outcome by about 20%, depending on the outcome.50 Second, most of the rates from 
published articles are neither age adjusted to a standard population nor adjusted for race/
ethnicity. Therefore, reported rates reflect differences in the underlying population, which is 
important because SAID diagnoses are known to peak in specific age and racial/ethnic 
groups. Third, although none of the studies in Table 5 relied on self-reported diagnoses, the 
criteria for becoming a case varied considerably. Fourth, the time period during which cases 
were accrued and the technological tools available for diagnosis varied over time, which is 
why we only included recent studies. Finally, because most SAIDs are relatively rare, 
published rates, including our own, should be validated.
Our study has several strengths. First, our REP coinvestigators provided age- and sex-
specific rates from a similar time period for the generation of expected FDNY rates, 
providing excellent population-based comparison rates for WTC-exposed males. Second, 
our cohort existed before 9/11, eliminating recruitment bias. Third, all persons in the cohort 
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had the opportunity to report SAID diagnoses on their monitoring questionnaires or to their 
FDNY physicians. Reports were screened, reviewed, and validated by our rheumatology 
case consultative review panel. Fourth, it is unlikely that members of our cohort had 
unrecognized pre-9/11 SAID because the physical demands of firefighting and EMS work 
would have made concealment difficult. Finally, information about WTC exposures was 
collected from questionnaires completed by all cohort members regardless of symptoms and, 
in most cases, were obtained years before the date of diagnosis, arguing against recall bias.
Study limitations include our lack of direct access to physician records outside the FDNY, 
which may have led to an underestimation of SAID incidence. For this reason, potential 
cases were reviewed by our team of rheumatologists. Second, we lacked an FDNY non—
WTC-exposed comparison group, potentially minimizing the effect of higher WTC exposure 
on SAID outcomes. Third, our results may not be generalizable to other occupational 
cohorts because our population was relatively small (~13,000), exclusively male, and mostly 
white and had above-average physical health before WTC exposure. Lastly, we lack 
information about family history of SAIDs and about non—WTC-related exposures, both 
work-related and recreational.
CONCLUSION
We found excess incident SAIDS in rescue/ recovery workers with higher WTC exposure. 
Because overall rates were within normal limits, higher incidence in specific subgroups 
might have been missed. Continued surveillance of WTC-exposed workers, particularly 
persons most highly exposed, is necessary to minimize the known effects of SAIDs and to 
understand the full spectrum of health consequences resulting from WTC exposure.
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TABLE 1
Incidence of Systemic Autoimmune Diseases Directly Standardized to the 2000 US Male Population Aged 18 
Years or Oldera
Systemic autoimmune disease FDNY cases Rateb (standardized) 95% CI
Rheumatoid arthritis 40 19.0 12.1–28.9
Spondyloarthritis 27 10.8 6.5–17.8
 Psoriatic arthritis 21 8.8 4.8–15.6
 Seronegative arthritis 3 1.0 0.2–5.5
 Ankylosing spondylitis 3 1.0 0.2–5.5
Systemic lupus erythematosus 11 5.1 2.0–11.6
Inflammatory myositis 9 6.6 2.0–15.6
 Polymyositis 7 6.0 1.5–15.0
 Dermatomyositis 2 0.7 0.1–5.2
Antiphospholipid syndrome 4 1.3 0.3–5.8
Sjögren syndrome 3 1.2 0.2–5.7
Systemic sclerosis (scleroderma) 2 0.8 0.1–5.3
GPA 1 0.3 0.0–4.8
Total 97 45.1 33.9–59.0
a
FDNY = Fire Department of the City of New York; GPA = granulomatosis with polyangiitis (formerly, Wegener granulomatosus).
b
Per 100,000 person-years. Combined rates may not equal sum of component rates due to rounding.
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TABLE 2
Observed and Expected Cases of SAIDs in the FDNY Cohort Based on Rates From the Rochester 
Epidemiology Project
Variable Observed Expected SIR (95% CI)
Entire FDNY cohort
 Rheumatoid arthritis 40.0 44.06 0.91 (0.65–1.24)
 Psoriatic arthritis 21.0 24.64 0.85 (0.53–1.30)
 Ankylosing spondylitis 3.0 8.48 0.35 (0.07–1.03)
 Systemic lupus erythematosus 11.0 1.50 7.33 (3.66–13.12)
 Sjögren syndrome 3.0 1.58 1.90 (0.39–5.55)
 Total 78.0 80.26 0.97 (0.77–1.21)
FDNY cohort by WTC exposure
 Higher WTC exposure
  Rheumatoid arthritis 10.0 11.71 0.85 (0.41–1.57)
  Psoriatic arthritis 11.0 7.30 1.51 (0.75–2.70)
  Ankylosing spondylitis 2.0 2.51 0.80 (0.10–2.88)
  Systemic lupus erythematosus 5.0 0.38 13.16 (4.27–30.71)
  Sjögren syndrome 2.0 0.42 4.76 (0.58–17.20)
  Total 30.0 22.32 1.34 (0.91–1.92)
 Lower WTC exposure
  Rheumatoid arthritis 30.0 32.35 0.93 (0.63–1.32)
  Psoriatic arthritis 10.0 17.34 0.58 (0.28–1.06)
  Ankylosing spondylitis 1.0 5.96 0.17 (0.0–0.93)
  Systemic lupus erythematosus 6.0 1.12 5.36 (1.97–11.66)
  Sjögren syndrome 1.0 1.16 0.86 (0.02–4.80)
  Total 48.0 57.93 0.83 (0.61–1.10)
FDNY = Fire Department of the City of New York; SAID = systemic autoimmune disease; SIR = standardized incidence ratio; WTC = World 
Trade Center.
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TABLE 3
Distribution of Systemic Autoimmune Diseases in the Fire Department of the City of New York Cohorta
Systemic autoimmune disease Confirmed (n=63) Probable (n=34) Total (N=97)
Rheumatoid arthritis 23 (36.5) 17 (50.0) 40 (41.2)
Spondyloarthritis 14 (22.2) 13 (38.2) 27 (27.8)
 Psoriatic arthritis 11 (17.5) 10 (29.4) 21 (21.6)
 Seronegative arthritis 0 (0.0) 3 (8.8) 3 (3.1)
 Ankylosing spondylitis 3 (4.8) 0 (0.0) 3 (3.1)
Systemic lupus erythematosus 9 (14.3) 2 (5.9) 11 (11.3)
Inflammatory myositis 9 (14.3) 0 (0.0) 9 (9.3)
 Polymyositis 7 (11.1) 0 (0.0) 7 (7.2)
 Dermatomyositis 2 (3.2) 0 (0.0) 2 (2.1)
Antiphospholipid syndrome 2 (3.2) 2 (5.9) 4 (4.1)
Sjögren syndrome 3 (4.8) 0 (0.0) 3 (3.1)
Systemic sclerosis (scleroderma) 2 (3.2) 0 (0.0) 2 (2.1)
Granulomatosis with polyangiitis (formerly, Wegener granulomatosis) 1 (1.6) 0 (0.0) 1 (1.0)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) 0 (0.0) 0 (0.0) 0 (0.0)
a
Data are presented as No. (percentage) of patients.
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TABLE 4
Selected Characteristics of the FDNY Cohorta,b
Variable Total cohort (N=13,892)
Participants with SAIDs 
(n=97)
Participants without SAIDs 
(n=13,795)
Race
 White 12,294 94 (96.0) 12,200 (88.4)
 Hispanic 853 3 (3.1) 850 (6.2)
 Black 658 0 (0.0) 658 (4.8)
 Asian 76 0 (0.0) 76 (0.6)
 Other 11 0 (0.0) 11 (0.1)
Class
 Fire department 12,338 93 (95.9) 12,245 (88.8)
 EMS 1548 4 (4.1) 1544 (11.2)
 Civilian 6 0 (0.0) 6 (0.04)
Age (y) on 9/11/2001, median (range) 39.7 (13.9–77.6) 44.1 (24.6–63.9) 39.6 (13.9–77.6)
Smoking status
 Never 8200 50 (51.6) 8150 (59.1)
 Ever 5692 47 (48.5) 5645 (40.9)
Chronic exposure
 High (≥7 mo on site) 2171 19 (19.6) 2152 (15.6)
 Low (≤6 mo on site) 11,721 78 (80.4) 11,643 (84.4)
Acute exposure on 9/11/2001
 Morning arrival 2156 22 (22.7) 2134 (15.5)
 Later arrival 11,736 75 (77.3) 11,661 (84.5)
Composite higher WTC exposure (9/11/2001 
AM arrival and/or duration ≥7 mo) 3912 36 (37.1) 3876 (28.1)
 Lower WTC exposure 9980 61 (62.9) 9919 (71.9)
a
EMS = emergency medical service worker; FDNY = Fire Department of the City of New York; SAID = systemic autoimmune disease; WTC = 
World Trade Center.
b
Data are presented as No. (percentage) of participants unless indicated otherwise.
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